Benjamin F. Edwards & Company’s Bristol-Myers Squibb BMY Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$3.94M	Buy	94,911 +5,382	+6%	+$241K	0.07%	261
2024 Q1	$4.86M	Buy	89,529 +34,660	+63%	+$1.77M	0.09%	218
2023 Q4	$2.82M	Sell	54,869 -173	-0.3%	-$9.08K	0.06%	281
2023 Q3	$3.19M	Sell	55,042 -24	-0%	-$1.47K	0.12%	166
2023 Q2	$3.52M	Buy	55,066 +3,552	+7%	+$238K	0.13%	158
2023 Q1	$3.57M	Buy	51,514 +4,228	+9%	+$298K	0.15%	145
2022 Q4	$3.4M	Sell	47,286 -1,782	-4%	-$134K	0.15%	145
2022 Q3	$3.49M	Sell	49,068 -4,173	-8%	-$303K	0.17%	129
2022 Q2	$4.1M	Sell	53,241 -11,717	-18%	-$892K	0.2%	125
2022 Q1	$4.74M	Sell	64,958 -23,277	-26%	-$1.56M	0.21%	106
2021 Q4	$5.5M	Sell	88,235 -4,732	-5%	-$278K	0.24%	93
2021 Q3	$5.5M	Sell	92,967 -3,681	-4%	-$242K	0.28%	79
2021 Q2	$6.46M	Buy	96,648 +11,786	+14%	+$769K	0.33%	74
2021 Q1	$5.36M	Buy	84,862 +1,848	+2%	+$115K	0.29%	80
2020 Q4	$5.15M	Buy	83,014 +19,326	+30%	+$1.19M	0.31%	74
2020 Q3	$3.84M	Buy	63,688 +4,183	+7%	+$252K	0.26%	90
2020 Q2	$3.5M	Buy	59,505 +3,248	+6%	+$194K	0.25%	96
2020 Q1	$3.14M	Sell	56,257 -1,507	-3%	-$92.1K	0.27%	92
2019 Q4	$3.71M	Buy	57,764 +7,695	+15%	+$441K	0.26%	94
2019 Q3	$2.54M	Buy	50,069 +22,206	+80%	+$1.04M	0.2%	128
2019 Q2	$1.26M	Buy	27,863 +11,066	+66%	+$515K	0.11%	203
2019 Q1	$801K	Buy	16,797 +3,732	+29%	+$186K	0.07%	261
2018 Q4	$679K	Sell	13,065 -1,799	-12%	-$96.7K	0.07%	260
2018 Q3	$923K	Buy	14,864 +597	+4%	+$35.4K	0.09%	240
2018 Q2	$790K	Sell	14,267 -10,845	-43%	-$586K	0.08%	261
2018 Q1	$1.59M	Buy	25,112 +4,025	+19%	+$259K	0.16%	137
2017 Q4	$1.29M	Sell	21,087 -382	-2%	-$23.9K	0.13%	169
2017 Q3	$1.37M	Buy	21,469 +2,474	+13%	+$144K	0.16%	137
2017 Q2	$1.06M	Buy	18,995 +865	+5%	+$47.1K	0.14%	156
2017 Q1	$986K	Buy	18,130 +4,150	+30%	+$228K	0.15%	150
2016 Q4	$817K	Buy	13,980 +3,564	+34%	+$195K	0.13%	169
2016 Q3	$562K	Buy	10,416 +4,650	+81%	+$299K	0.1%	211
2016 Q2	$424K	Buy	5,766 +194	+3%	+$13.7K	0.08%	229
2016 Q1	$356K	Sell	5,572 -900	-14%	-$56.8K	0.07%	237
2015 Q4	$445K	Buy	6,472 +1,033	+19%	+$68.3K	0.1%	205
2015 Q3	$322K	Sell	5,439 -4,698	-46%	-$298K	0.07%	248
2015 Q2	$675K	Sell	10,137 -3,221	-24%	-$212K	0.13%	163
2015 Q1	$862K	Buy	13,358 +1,611	+14%	+$101K	0.18%	127
2014 Q4	$693K	Sell	11,747 -3,199	-21%	-$180K	0.16%	144
2014 Q3	$765K	Buy	14,946 +4,590	+44%	+$229K	0.19%	125
2014 Q2	$502K	Buy	10,356 +400	+4%	+$19.7K	0.13%	168
2014 Q1	$517K	Sell	9,956 -6,087	-38%	-$324K	0.14%	161
2013 Q4	$853K	Sell	16,043 -2,850	-15%	-$145K	0.29%	90
2013 Q3	$874K	Buy	18,893 +6,200	+49%	+$272K	0.32%	78
2013 Q2	$567K	Buy	+12,693	New	+$551K	0.23%	120

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Benjamin F. Edwards & Company's BMY Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2024, buying an estimated $241K and bringing the position to 94,911 shares worth $3.94M. The position accounts for 0.07% of the portfolio, ranked #261.

Benjamin F. Edwards & Company first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.46M in Q2 2021. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Benjamin F. Edwards & Company held 94,911 shares of Bristol-Myers Squibb worth $3.94M as of Q2 2024.
Benjamin F. Edwards & Company bought 5,382 Bristol-Myers Squibb shares in Q2 2024, an estimated $241K.
Bristol-Myers Squibb made up 0.07% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #261 holding.
Benjamin F. Edwards & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
Benjamin F. Edwards & Company's Bristol-Myers Squibb position peaked at $6.46M in Q2 2021.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.